As of Sep 30, 2024, Amedisys, Inc.'s fair value using the Ben Graham formula is ($10.4K) per share. This is calculated using Ben Graham formula, where EPS is $3.9 and BVPS (Book Value Per Share) is $36.7. The current price of $90.4 suggests Amedisys, Inc. may be overvalued by this conservative metric.
Amedisys, Inc. earnings per share (EPS) for the twelve months ending Sep 30, 2024, was $3.9, a (1,561.8%) growth year-over-year.
Amedisys, Inc.'s margin of safety is negative 11,651.3%, calculated as (Graham Number - Current Price) / Current Price. A negative margin of safety suggests the stock doesn't provide the level of safety Graham typically sought in his investments.